$0.070
(0%)
|
High - |
Low - |
Trades - |
Turnover $0 |
Volume 0 |
| 13 November 2026 at 10:02am | ||||
RHINOMED LIMITED
Pharmaceuticals, Biotechnology & Life Sciences
|
Market Cap (13-Nov) $11,471,000 (1,037th) |
Close (30-Jun) $0.070 |
Volume (30-Jun) 0 |
Shortsold (8-Jan) 4,400 (0.00%) (473rd) |
|
52w High $0.000 |
52w Low $0.000 |
P/E - |
EPS -0.04 |
Quarterly Activities/Appendix 4C Cash Flow Report
RNO released this announcement to the ASX on 31 October 2022, 9:03. The announcement is marked as price sensitive, and is 12 page(s) in length and 701.1kb in size.
You can view all announcements from RNO and see how they appear on a price chart on the announcements page.
| Other Recent Announcements from RNO | |
|---|---|
| Change in substantial holding WG | 18 May 2023, 9:23 |
| App 3Y MJ | 4 May 2023, 10:56 |
| Quarterly Activities/Appendix 4C Cash Flow Report | 28 April 2023, 9:19 |
| Quarterly Activities/Appendix 4C Cash Flow Report | 31 October 2022, 9:03 |
| Microcap Investor Conference presentation | 19 October 2022, 9:50 |
| Annual Report to shareholders | 17 October 2022, 14:01 |
| Notice of Annual General Meeting/Proxy Form 2022 | 17 October 2022, 9:39 |
If you were already registered, log in here.
If you were already registered, log in here.